专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

US20060207939A1 Separation system, components of a separation system and methods of making and using them 有权
标题翻译：分离系统，分离系统的组成部分以及制造和使用它们的方法
公开(公告)号：US20060207939A1
公开(公告)日：2006-09-21
申请号：US11337071
申请日：2006-01-19
申请人： Robert Allington , Shaofeng Xie , Tao Jiang , Mingcheng Xu
发明人： Robert Allington , Shaofeng Xie , Tao Jiang , Mingcheng Xu
IPC分类号： B01D15/08
CPC分类号： B01J20/3064 , B01D15/206 , B01J8/0005 , B01J19/0013 , B01J19/18 , B01J20/283 , B01J20/285 , B01J2219/00162 , B01J2220/54 , B01J2220/82 , G01N30/56 , G01N2030/522 , G01N2030/528 , G01N2030/567 , G01N30/30
摘要： Permeable polymeric monolithic materials are prepared in a column casing. In one embodiment, the permeable polymeric monolithic materials are polymerized while pressure is applied through a piston having a smooth piston head in contact with the polymerization mixture. The pressure eliminates wall effect and changes the structure in the column. Similarly, some columns that have a tendency to swell in the presence of aqueous solutions and pressurized while the solution is applied to prevent swelling and wall effect. This procedure also changes the structure in the column. The size of the separation effective openings can be controlled by the amount of the pressure and pores eliminated. Uniformity in the direction flow is improved by controlling polymerization with radiation rather than with conducted heat.
摘要翻译：在柱套管中制备可渗透的聚合物整体材料。在一个实施方案中，可渗透的聚合物整体材料在通过具有与聚合混合物接触的平滑活塞头的活塞施加压力时聚合。压力消除了墙壁效应并改变了柱子的结构。类似地，一些在水溶液存在下具有溶胀倾向并在施加溶液时加压以防止膨胀和壁效应的柱。此过程也会更改列中的结构。分离有效开口的尺寸可以通过消除的压力和孔隙的量来控制。通过用辐射而不是传导热来控制聚合来提高方向流动的均匀性。

32. 发明申请

US20060161632A1 System and method for voice over internet protocol communication using an instant messenger 审中-公开
标题翻译：使用即时通讯方式进行语音互联网协议通信的系统和方法
公开(公告)号：US20060161632A1
公开(公告)日：2006-07-20
申请号：US11318292
申请日：2005-12-23
申请人： Haijun Wu , Tao Jiang , Yan Chen , Bo Wu
发明人： Haijun Wu , Tao Jiang , Yan Chen , Bo Wu
IPC分类号： G06F15/16
CPC分类号： H04L51/04 , H04M1/2478 , H04M1/2535
摘要： Disclosed herein is a system and method for Voice over Internet Protocol (VoIP) communication using an instant messenger (IM). The disclosed system sets up a phone terminal connected with the IM and set up a phone control module inside the IM. The disclosed method generally carries out the sending and receiving of instructions as well as carrying out voice processing through said phone terminal so as to accomplish voice-information communications between the calling and called terminals. The disclosed system and method provide a more practical technique, inasmuch as the set phone terminal may connect with the IM via a USB port or IEEE 1394 port. With the disclosed method and system, the drawbacks of current methods of phone communications using IM are overcome while the operation remains simple.
摘要翻译：本文公开了使用即时消息（IM）的基于因特网协议语音（VoIP）通信的系统和方法。所公开的系统设置与IM连接的电话终端，并在IM内设置电话控制模块。所公开的方法通常执行指令的发送和接收以及通过所述电话终端进行语音处理，以便在主叫和被叫终端之间完成语音信息通信。所公开的系统和方法提供了更实用的技术，因为所设置的电话终端可以经由USB端口或IEEE 1394端口与IM连接。利用所公开的方法和系统，克服当前使用IM的电话通信方法的缺点，同时操作保持简单。

33. 发明授权

US07060697B2 Immunosuppressant compounds and compositions 失效
公开(公告)号：US07060697B2
公开(公告)日：2006-06-13
申请号：US10849079
申请日：2004-05-19
申请人： Thomas H. Marsilje , Nathanael S. Gray , Tao Jiang , Wenshuo Lu , Shifeng Pan
发明人： Thomas H. Marsilje , Nathanael S. Gray , Tao Jiang , Wenshuo Lu , Shifeng Pan
IPC分类号： A61K31/397 , A61K31/40 , A61K31/197 , C07D207/06 , C07D205/04
CPC分类号： C07C323/32 , C07C317/32 , C07C2601/14 , C07D205/04
摘要： The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

34. 发明申请

US20060122826A1 Device and method for reducing stuttering 有权
标题翻译：减少口吃的装置和方法
公开(公告)号：US20060122826A1
公开(公告)日：2006-06-08
申请号：US11001722
申请日：2004-12-02
申请人： Tao Jiang , Xiaoyi Fu , Yining Jiang , Shixiong Xia , Alan Newton
发明人： Tao Jiang , Xiaoyi Fu , Yining Jiang , Shixiong Xia , Alan Newton
IPC分类号： G10L19/14
CPC分类号： G10L21/0208 , A61F5/58 , G09B19/04 , G10L2021/0575
摘要： The present invention is directed to a wearable stutter reducing device incorporating novel methods that make extensive use of digital signal processing (DSP) technology. The wearable stutter reducing device of the present invention has an audio signal receiver for receiving speech signals corresponding to a wearer's voice. An input conversion means for converting the speech signals and noise mixed with the speech signals into frequency domain components is in communication with the audio signal receiver. A channelization means in communication with the conversion means separates the frequency domain components into a plurality of channels. An identifying means in communication with the plurality of channels identifies which channels of the plurality of channels contain substantially more speech corresponding frequency domain components than noise corresponding frequency components. An amplification means for amplifying signals identified as speech is in communication with the identifying means. The present invention also includes a frequency altering means for altering the frequency of a predetermined number of channels and an output conversion means in communication with the amplification means for converting the frequency components into time domain signals containing amplified speech.
摘要翻译：本发明涉及一种包含广泛使用数字信号处理（DSP）技术的新颖方法的可穿戴式口吃减少装置。本发明的可穿戴式口吃减少装置具有用于接收对应于佩戴者声音的语音信号的音频信号接收器。用于将语音信号和与语音信号混合的噪声转换成频域分量的输入转换装置与音频信号接收器通信。与转换装置通信的信道化装置将频域分量分离成多个信道。与多个信道通信的识别装置识别出多个信道中的哪些信道比噪声对应的频率分量包含更多的语音对应的频域分量。用于放大识别为语音的信号的放大装置与识别装置通信。本发明还包括用于改变预定数量信道的频率的频率改变装置和与放大装置通信的输出转换装置，用于将频率分量转换成包含放大语音的时域信号。

35. 发明申请

US20050014725A1 Immunosuppressant compounds and compositions 有权
公开(公告)号：US20050014725A1
公开(公告)日：2005-01-20
申请号：US10849458
申请日：2004-05-19
申请人： Yuan Mi , Shifeng Pan , Nathanael Gray , Wenqi Gao , Yi Fan , Tao Jiang
发明人： Yuan Mi , Shifeng Pan , Nathanael Gray , Wenqi Gao , Yi Fan , Tao Jiang
IPC分类号： A61K31/185 , A61K31/195 , A61K31/41 , A61K31/66 , A61K31/675 , C07D333/60 , C07F9/28
CPC分类号： C07D333/58 , C07D261/20 , C07D409/06 , C07D471/04 , C07D473/00 , C07D513/04
摘要： The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

36. 发明申请

US20050004077A1 Novel bisamidate phosphonate prodrugs 审中-公开
标题翻译：新型双酰胺基膦酸酯前药
公开(公告)号：US20050004077A1
公开(公告)日：2005-01-06
申请号：US10900718
申请日：2004-07-28
申请人： Tao Jiang , Srinivas Kasibhatla , K. Reddy
发明人： Tao Jiang , Srinivas Kasibhatla , K. Reddy
IPC分类号： A61K31/665 , A61K31/675 , A61P3/10 , A61P43/00 , C07F9/44 , C07F9/58 , C07F9/6509 , C07F9/6512 , C07F9/653 , C07F9/6539 , C07F9/6541 , C07F9/655 , C07F9/6561
CPC分类号： C07F9/6561 , C07F9/4465 , C07F9/65515
摘要： Novel bisamidate phosphonate prodrugs of FBPase inhibitors of the Formula IA: and their use in the treatment of diabetes and other conditions associated with elevated blood glucose.
摘要翻译：式IA的FBP酶抑制剂的新型双酰胺基膦酸酯前体药物及其在治疗与血糖升高相关的糖尿病和其它病症中的用途。

37. 发明授权

US6055369A Apparatus for visual programming with screen flow 失效
标题翻译：屏幕流程视觉编程设备
公开(公告)号：US6055369A
公开(公告)日：2000-04-25
申请号：US852033
申请日：1997-05-06
申请人： Tomoharu Sawahata , Wei-Tek Tsai , Akira K. Onoma , Tao Jiang
发明人： Tomoharu Sawahata , Wei-Tek Tsai , Akira K. Onoma , Tao Jiang
IPC分类号： G06F9/06 , G06F9/44 , G06F9/445
CPC分类号： G06F8/34
摘要： An apparatus is disclosed for visual programming for creating a program with a visual user interface. The visual programming apparatus has a screen storage unit for storing multiple screens to be employed with the program; a screen creating unit for creating the multiple screens to be employed with the program and storing the multiple screens in the screen storage unit; a screen flow creating unit for creating a screen flow indicating a flow of processes by displaying on an edit screen the multiple screens stored in the screen storage unit in a compressed manner and specifying a link between the multiple compressed screens on the edit screen; a screen flow information extracting unit for extracting data of a link from the screen flow created by the screen flow creating unit; and a code creating unit for creating a source code from the data of the link extracted by the screen flow information extracting unit and from data of the screen.
摘要翻译：公开了一种用于可视化编程的装置，用于创建具有可视用户界面的程序。视觉编程装置具有屏幕存储单元，用于存储要与节目一起使用的多个屏幕; 用于创建要与程序一起使用的多个屏幕并将多个屏幕存储在屏幕存储单元中的屏幕创建单元; 屏幕流创建单元，用于通过在编辑屏幕上以压缩的方式显示存储在屏幕存储单元中的多个屏幕并指定编辑屏幕上的多个压缩屏幕之间的链接来创建指示流程的屏幕流程; 屏幕流信息提取单元，用于从由屏幕流创建单元创建的屏幕流提取链接的数据; 以及代码创建单元，用于从由屏幕流信息提取单元提取的链接的数据和从屏幕的数据创建源代码。

38. 发明授权

US5955453A Membrane-permeant phosphoinositides 失效
标题翻译：膜透性磷酸肌醇
公开(公告)号：US5955453A
公开(公告)日：1999-09-21
申请号：US066037
申请日：1998-04-24
申请人： Roger Y. Tsien , Tao Jiang
发明人： Roger Y. Tsien , Tao Jiang
IPC分类号： C12Q1/02 , A61K31/66 , A61P43/00 , C07F9/117 , C07F9/10 , C07F9/177 , C07F9/24
CPC分类号： C07F9/117 , A61K31/66
摘要： Membrane-permeant phosphoinositides, including phosphatidylinositol phosphate esters, are described. A membrane-permeant phosphoinositide includes groups that neutralize the charges of the phosphate moieties of the phosphoinositide. A cell can be treated with the membrane-permeant phosphoinositide, which is then absorbed into the cell. The neutralizing groups can be removed intracellularly to afford the charged phosphoinositide.
摘要翻译：描述了膜 - 渗透性磷酸肌醇，包括磷脂酰肌醇磷酸酯。膜透性磷酸肌醇包括中和磷酸肌醇的磷酸酯部分的电荷的基团。可以用膜透过性磷酸肌醇治疗细胞，然后将其吸收到细胞中。可以在细胞内除去中和基团，得到带电的磷酸肌醇。

39. 外观设计

USD946004S1 Screen swivel mount 有权
公开(公告)号：USD946004S1
公开(公告)日：2022-03-15
申请号：US29796129
申请日：2021-06-22
申请人： Tao Jiang
设计人： Tao Jiang

40. 发明授权

US08592432B2 Compounds and compositions as protein kinase inhibitors 失效
标题翻译：化合物和组合物作为蛋白激酶抑制剂
公开(公告)号：US08592432B2
公开(公告)日：2013-11-26
申请号：US12936199
申请日：2009-04-03
申请人： Bei Chen , Tao Jiang , Thomas H. Marsilje , Pierre-Yves Michellys , Truc Ngoc Nguyen , Wei Pei , Baogen Wu , Zhaobo Gao , Yonghui Ge , Chen Huang , Yuncheng Li , Xuefeng Zhu
发明人： Bei Chen , Tao Jiang , Thomas H. Marsilje , Pierre-Yves Michellys , Truc Ngoc Nguyen , Wei Pei , Baogen Wu , Zhaobo Gao , Yonghui Ge , Chen Huang , Yuncheng Li , Xuefeng Zhu
IPC分类号： A61K31/506 , A61K31/5377 , C07D239/42 , C07D239/30 , C07D295/108 , C07D487/04 , A61P35/00 , A61P35/02 , A61P35/04
CPC分类号： C07D239/48 , C07D403/12 , C07D403/14 , C07D487/04
摘要： The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-1R), and/or insulin receptor (InsR) or a combination thereof.
摘要翻译：本发明提供新颖的嘧啶衍生物及其药物组合物，以及使用这些化合物的方法。例如，本发明的嘧啶衍生物可用于治疗，改善或预防对间变性淋巴瘤激酶（ALK）活性，c-ros致癌基因（ROS），胰岛素样生长因子（IGF-1R ）和/或胰岛素受体（InsR）或其组合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式